Orange Book product · Brand (NDA)
CORDRAN
FLURANDRENOLIDE
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
FLURANDRENOLIDE
Strength
0.004MG/SQ CM
Dosage form
TAPE
Route
TOPICAL
TE code
Not listed
Application
NDA 016455
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- —CORDRAN SPBrand (NDA)
NDA 012806 · INA PHARMS
- —CORDRANBrand (NDA)
NDA 013790 · INA PHARMS
- 2016FLURANDRENOLIDEGeneric (ANDA)
ANDA 207851 · TELIGENT
- 2016FLURANDRENOLIDEGeneric (ANDA)
ANDA 205343 · CHARTWELL RX
- 2016FLURANDRENOLIDEGeneric (ANDA)
ANDA 207133 · PADAGIS ISRAEL
- 2016FLURANDRENOLIDEGeneric (ANDA)
ANDA 205342 · CHARTWELL RX
- 1982FLURANDRENOLIDEGeneric (ANDA)
ANDA 087203 · ALPHARMA US PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
